From idea to impact: accelerating the promise of early science

By Christelle Huguet, EVP & Head of R&D, Ipsen Every year, new breakthroughs reveal possibilities for treating conditions once thought

Published
Categorized as Science

A model for modern biopharma collaboration — the enduring partnership between Ipsen and IRICoR

In an era where breakthrough science increasingly depends on deep, cross sector collaboration, the longstanding partnership between Ipsen and the

Published
Categorized as Science

A Life in Science: Adapting science through diverse perspectives

New in our A Life in Science series, we hear from Florence Meyer-Losic, Vice President and Head of Translational Sciences, about her

Published
Categorized as Science

A Life in Science: Teamwork and resilience in early development 

New in our A Life in Science series, we hear from Eli Leo, Early Development Asset Lead, about how teamwork, creativity, and

Published
Categorized as Science

Defining the path: Lineu Domit on the role of safety in early development

“Our role is to anticipate things: ‘Which dose is safe, which populations face higher risk, and how can we mitigate

Published
Categorized as Science

Closing Care Gaps in Post‑Stroke Spasticity

By Sandra Silvestri, EVP & Chief Medical Officer, Ipsen At Ipsen, our heritage in neuroscience has always been about more

Published
Categorized as Science

Bridging science and leadership: Elisabetta Leo on guiding early development at Ipsen

“I felt, during my career path, that I was more a scientist rather than a leader; in my current role,

Published
Categorized as Science

Acquired Science. Accelerated Impact. Ipsen’s Determined M&A Strategy Is Rewriting the Rules of Innovation

Philippe Lopes-Fernandes, EVP & Chief Business Officer, shares how Ipsen’s tenacious approach to dealmaking is transforming breakthrough science into global

Published
Categorized as Science

Designing for precision: A passion for innovation with Will Olughu

“We all know someone affected by cancer, so for me, there’s an urgency, especially when I think about the patient.”

Published
Categorized as Science

Bold Science, Bold Ambition: Shaping the Future of Oncology at Ipsen

Ivan Diaz-Padilla, Senior Vice President and Global Head, Oncology Therapeutic Area Unit, R&D at Ipsen, shares his vision for building

Published
Categorized as Science